These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2031964)

  • 21. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).
    Bene MC; Castoldi G; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer MB
    Leukemia; 1995 Oct; 9(10):1783-6. PubMed ID: 7564526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy.
    Gutierrez A; Kentsis A
    Br J Haematol; 2018 Mar; 180(6):919-924. PubMed ID: 29441563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphology and classification of acute myeloid leukemias.
    Krause JR
    Clin Lab Med; 2000 Mar; 20(1):1-16. PubMed ID: 10702892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modern classification of the acute non-lymphoblastic leukaemias.
    Hayhoe FG
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():70-2. PubMed ID: 2653522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute leukaemia in children--French-American-British (FAB) classification and its relation to clinical features.
    Hassan K; Bukhari KP; Zafar A; Malik MZ; Akhtar MJ
    J Pak Med Assoc; 1992 Feb; 42(2):29-31. PubMed ID: 1573762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current concerns in haematology. 2: Classification of acute leukaemia.
    Bain B; Catovsky D
    J Clin Pathol; 1990 Nov; 43(11):882-7. PubMed ID: 2262557
    [No Abstract]   [Full Text] [Related]  

  • 28. Myeloperoxidase-deficient polymorphonuclear leucocytes. (IV): Relation to FAB-classification in acute myeloid leukaemia.
    Bendix-Hansen K; Nielsen HK
    Scand J Haematol; 1985 Aug; 35(2):174-7. PubMed ID: 2996122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Image analysis detects lineage-specific morphologic markers in leukemic blast cells.
    Baumann I; Nenninger R; Harms H; Zwierzina H; Wilms K; Feller AC; Ter Meulen V; Müller-Hermelink HK
    Am J Clin Pathol; 1996 Jan; 105(1):23-30. PubMed ID: 8561083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients.
    Bacher U; Kern W; Schnittger S; Hiddemann W; Schoch C; Haferlach T
    Ann Hematol; 2005 Nov; 84(12):785-91. PubMed ID: 16132906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression.
    Legrand O; Perrot JY; Simonin G; Baudard M; Cadiou M; Blanc C; Ramond S; Viguié F; Marie JP; Zittoun R
    Br J Haematol; 1998 Jan; 100(1):147-55. PubMed ID: 9450804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The diagnostic significance of blast immunophenotype assay in patients with acute leukemia].
    Piatoska-Jakubas B; Pituch-Noworolska A; Skotnicki AB; Balana-Nowak A
    Acta Haematol Pol; 1996; 27(1):33-41. PubMed ID: 8629441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies.
    Horny HP; Wehrmann M; Steinke B; Kaiserling E
    Hum Pathol; 1994 Aug; 25(8):810-4. PubMed ID: 8056422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
    Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cytogenetics of childhood acute myelogenous leukaemias.
    Leblanc T; Berger R
    Eur J Haematol; 1997 Jul; 59(1):1-13. PubMed ID: 9260575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification.
    San Miguel JF; Gonzalez M; Cañizo MC; Anta JP; Zola H; Lopez Borrasca A
    Br J Haematol; 1986 Nov; 64(3):547-60. PubMed ID: 3466644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations.
    Huret JL; Brizard A; Slater R; Charrin C; Bertheas MF; Guilhot F; Hählen K; Kroes W; van Leeuwen E; Schoot EV
    Leukemia; 1993 Feb; 7(2):152-60. PubMed ID: 8426468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytochemical, immunologic and gene rearrangement studies in adult acute leukemia].
    Pálóczi K; Natonek K; Mód A; Poros A; Mihalik R; Földi J; Benczur M; Hollán Z
    Orv Hetil; 1990 May; 131(21):1119-24. PubMed ID: 2194149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetics and immunophenotype.
    Mecucci C; van den Berghe H
    Leuk Lymphoma; 1994; 13 Suppl 1():49-51. PubMed ID: 8075580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.